A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

The WHO has classified XFG or ‘Stratus’ as a variant under monitoring. It may well become the dominant variant globally very ...

SARS-CoV-2 spike protein persisted in the skull and brain, mouse and human autopsy data showed. In mouse models and human postmortem samples, SARS-CoV-2 spike protein was found in the skull marrow ...

New research reveals that mutations in the stem of the SARS-CoV-2 spike protein led to the virus becoming progressively tighter over time, which may have improved the virus's ability to transmit ...

The spike protein of SARS-CoV-2, the virus that causes COVID-19, has been the focus of a lot of research these past two years. It’s what the virus uses to invade host cells and it has been the ...

The new finding does not necessarily mean that SARS-CoV-2 is more likely to bind to cell receptors, but it does mean that its spike protein has a better chance of effective binding.

Researchers directly compared the pre-fusion spikes of SARS-CoV-2 Alpha and Beta variants with the original Wuhan strain and the D614G-only variant.

New research indicates that SARS-CoV-2 may be able to impact viral pathogenesis without entering host cells— extracellular binding of the spike protein to host ACE2 has the potential to alter ...

Using a newly developed mouse model of acute lung injury, researchers found that exposure to the SARS-CoV-2 spike protein alone was enough to induce COVID-19-like symptoms including severe ...

A new, detailed model of the surface of the SARS-CoV-2 spike protein reveals previously unknown vulnerabilities that could inform development of vaccines.